↓ Skip to main content

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis

Overview of attention for article published in BMC Cancer, June 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
64 Mendeley